Apoptosis and cancer;Apoptose et cancer

Bulletin de l'Academie Nationale de Medecine

Volumn 183, Issue 2, 1999, Pages 277-287

  Agnantis, Niki J ^a   Goussia, Ann C ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b NONE

Author keywords

Apoptosis; Neoplasms

Indexed keywords

APOPTOSIS; HUMAN; NECROSIS; NEOPLASM; PATHOLOGY; PHYSIOLOGY; REVIEW;

APOPTOSIS; HUMANS; NECROSIS; NEOPLASMS;

EID: 0042912108     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. KERR JFR., WYLLIE AH., CURRIE AR. - Apoptosis : a basic biological phenomenon with wide ranging implications in tissue kinetics. Br. J. Cancer., 1972, 26, 239-257.
2. WYLLIE AH., KERR JFR., CURRIE AR. - Cell death : the significance of apoptosis. Int. Rev. Cytol., 1980, 68, 251-306.
3. ELLIS HM., HORVITZ HR. - Genetic control of programmed cell death in the nematode C. Elegans. Cell, 1986, 44, 817-829.
4. HENGARTNER MO., HORVITZ HR. - C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell, 1994, 76, 665-676.
5. KORSMEYER SJ. - Bcl-2 : an antidote to programmed cell death. Cancer Surv, 1992, 15, 105-118.
6. VAUX DL. - Toward an understanding of the molecular mechanisms of physiological cell death. Proc. Natl. Acad. Sci. USA, 1993, 90, 786-789.
7. WANG L., MIURA M., BERGERON L., ZHU H., YUAN J. - Ich-1, and Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell, 1994, 78, 739-750.
8. KAMENS J., PASKIND M., HUGUNIN M. - Indentification and characterization of ICH-2, a novel member of the interleukin -1b - converting enzyme family of cysteine proteases. J. Biol. Chem., 1995, 270, 15250-15256.
9. FAUCHEN C., DIU A., CHAN AWE. - A novel human protease similar to the interleukin -1â converting enzyme induces apoptosis in transfected cells. Embo. J., 1995, 14, 1914-1922.
10. TEWARI M., QUAN LT., O'ROURKE K., DESNOYERS S., ZENG Z., BEIDLER DR., POIRIER GG., SALVESEN GS., DIXIT VM. - Yama/CPP32â, a mammalian homolog of CED-3, is a CrmA -inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell, 1995, 81, 801-809.
11. THORNBERRY NA., LAZEBNIK Y. - Caspases : Enemies Within. Science, 1998, 281, 1312-1316.
12. ARENDS MJ., MORRIS RJ., WYLLIE AH. - Apoptosis : the role of the endonuclease. Am. J. Pathol., 1990, 136, 593-608.
13. WYLLIE AH. - Glucocorticoid - induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature, 1980, 284, 555-556.
14. COHEN JJ., DUKE RC. - Glucocorticoid activation of a calcium -dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol., 1984, 132, 38-42.
15. RESNICOFF M., ABRAHAM D., YUTANAWIBOUNCHAI W., ROTMAN HL., KAJSTURA J., RUBIN R., ZOLTICK P., BASERGA R. - The insulin - like growth factor I receptor protects tumour cells from apoptosis in vivo. Cancer Res., 1995, 55, 2463-2469.
16. REED JC. - Bcl-2 and the regulation of programmed cell death. J. Cell. Biol., 1994, 124, 1-6.
17. TSUJIMOTO Y., CROCE CM. - Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA, 1986, 83, 5214-5218.
18. GREEN DR., REED JC. - Mitochondria and Apoptosis. Science, 1998, 281, 1309-1312.
19. ADAMS JM., CORY S. - Transgenic models for haemopoietic malignancies. Biochim Biophys Acta, 1994, 7072, 9-31.
20. STRASSER A., HARRIS AW., BATH ML., CORY S. - Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature, 1990, 348, 331-333.
21. HARRINGTON E., FANIDI A., EVAN G. - Oncogenes and cell death. Curr Opin Genet Dev, 1994, 4, 120-129.
22. YANG E., ZHA J., JOCKEL J., BOISE LH., THOMPSON CB., KORSMEYER SJ. - Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell, 1995, 80, 285-291.
23. REED JC., MEISTER L., TANAKA S., CUDDY M., YUM S., GEYER C., PLEASURE D. - Differential expression of bcl-2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res., 1991, 51, 6529-6538.
24. BEN-EZRA JM., KORNSTEIN MJ., GRIMES MM., KRYSTAL G. - Small cell carcinomas of the lung express the Bcl-2 protein. Am. J. Pathol., 1994, 145, 1036-1040.
25. PLETTENBERG A., BALLAUM C., PAMMER J., MILDNER M., STRUNK D., WENINGER T., TSCHACHLER E. - Human melanocytes and melanoma cells constitutively express the Bcl-2 protooncogene in situ and in cell culture. Am. J. Pathol., 1995, 146, 651-659.
26. MCDONNELL TJ., TRONCOSO P., BRISBAY SM., LOGOTHETIS C., CHUNG LWK., HSIEH J-T., TU SM., CAMPBELL ML. - Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res., 1992, 52, 6940-6944.
27. PILLOTI S., COLLINI P., RILKE F., CATTORETTI G., DEL BO RD., PIEROTTI MA. - Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J. Pathol., 1994, 172, 337-342.
28. DOGLIONI C., DEITOS AP., LAURINO L., CHIARELLI C., BARBARESCHI M., VIALE G. - The prevalence of bcl-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status. Virchows Arch., 1994, 424, 45-51.
29. MALAMOU-MITSI V., IOACHIM E., KAMINA S., CHARCHANTI A., AGNANTIS NJ. - Immunohistochemical study of cell proliferation and apoptosis markers in breast neoplasia. Anticancer Res., 1997, 17, 4012-4013.
30. SHIINA H., IGAWA M., URAKAMI S., HONDA S., SHIRAKAWA H., ISHIBE T. - Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder. J. Clin. Pathol., 1996, 49, 395-399.
31. LAUWERS G.Y., SCOTT G.V., KARPE H. - Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer, 1995, 75, 2209-2213.
32. WATSON A.J.M., MERRITT A.J., JONES L.S., ASKEW JN., ANDERSON E., BECCIOLINI A., BALZI M., POTTEN C.S., HICKMAN J.A. - Evidence for reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas. Br. J. Cancer., 1996, 73, 889-895.
33. SKOPELITOU A., HADJIYANNAKIS M., ALEXOPOULOU V., KRIKONI O., KAMINA S., AGNANTIS N. - Topographical Immunohistochemical Expression of Bcl-2 Protein in Human Liver Lesions. Anticancer Res., 1996, 16, 975-978.
34. GOUSSIA AC., IOACHIM E., AGNANTIS NJ., MAHERA M., TSIANOS EV. - Bcl-2 expression in colorectal tumours. Correlation with p53, mdm-2, Rb proteins and proliferating indices. Pathol Res Practice, 1998 (in press).
35. MIYASHITA T., REED JC. - Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in human leukemia cell line. Blood, 1993, 81, 151-157.
36. HOCKENBERY D., OLTVAI Z., YIN X., MILLIMAN C., SJK. - Bcl-2 functions is an antioxidant pathway to prevent apoptosis. Cell., 1993, 75, 241-251.
37. 2+ fluxes. Proc. Natl. Acad. Sci. USA, 1994, 91, 6569-6573.
38. HOLLSTEIN M., SIDRANSKY D., VOGELSTEIN B., HARRIS C.C. - p53 mutations in human cancers. Science, 1991, 253, 49-53.
39. LANE D.P. - P53, guardian of the genome. Nature, 1992, 358, 15-16.
40. YONISH-ROUACH E., GRUNWALD D., WILDER S., KIMCHI A., MAY E., LAWRENCE JJ., MAY P., ORENM. - p53 mediated cell death : relationship to cell cycle control. mol. Cell. Biol., 1993, 13, 1415-1423.
41. LOTEM J., SACHS L. - Regulation by bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation - competent and differentiation - detective myeloid leukemic cells. Cell. Grth. Diff., 1993, 4. 41-47.
42. MIYASTITA T., REED JC. - Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 1995, 80, 293-299.
43. KNUDSON AG. - Mutation and cancer : statistical study of retinoblastoma. Proc Natl Acad Sci. USA, 1971, 65, 820-823.
44. HOOPER ML. - The role of the p53 and Rb-1 genes in cancer, development and apoptosis. J. Cell. Sci., 1994, 18 (Suppl), 13-17.
45. HUNTER T., PINES J. - Cyclins and cancer II : cyclin D and CDK inhibitors come of age. Cell, 1994, 79, 573-582.
46. LEVINE AJ. - The tumor suppressor genes. Annu. Rev. Biochem., 1993, 62, 623-651.
47. LEE E.V., CHANG C.Y., HU N., WANG Y.C., LAI C.C., HERRUP K., LEE W.H., BRADLEY A. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature, 1992, 359, 288-294.
48. HICKMAN JA. - Apoptosis induced by anticancer drugs. Cancer Metastasis, 1992, 11, 121-139.